For the first time, we showed significant differences between patients with low versus high infiltrates of CD20+ B cells not only in the clinical outcome but also in the activation status of TIL-Bs and the density of tumor-infiltrating HPV 16 E6/E7-specific CD8+ T cells. Here, MS4A1 is linked to neoplasm.